via CCSVI in Multiple Sclerosis - "The first death in Tecfidera. A poor woman passes due to pneumonia, yet Biogen says it wasn't their drug. Don't they understand that Tecfidera depletes lymphocytes? This stops the immune system from fighting a bacterial infection like pneumonia, even weeks after discontinuing the drug, lymphocyte levels can remain low. It may seem like a "non-issue" to Wall Street...but to the thousands of patients who are now on this drug and depleting their lymphocyte levels, it's a cause for concern." http://www.forbes.com/sites/edsilverman/2013/07/22/biogen-unlikely-patient-death-was-caused-by-tecfidera/


Biogen: It's Unlikely Patient Death Was Caused By Tecfidera
www.forbes.com
After rampant speculation that its new Tecfidera multiple sclerosis drug caused a patient death, the biotech says that it is unlikely the pill was responsible.